Amgen disclosed that it has agreed with Kyowa Kirin to terminate their License and Collaboration Agreement dated June 1, 2021. The decision was formalized through a Termination Agreement signed on January 30, 2026, and the termination will become effective once the required regulatory approval is obtained. No additional financial details were disclosed in the filing.